How do you approach a patient with recurrent VTE who develops VTE again after reduction of apixaban to 2.5 mg bid?
Would you consider increasing the dose to the usual 5 mg BID or consider it a DOAC failure and switch to coumadin?
Community PollStarted
How do you approach a patient with recurrent VTE who develops VTE again after reduction of apixaban to 2.5 mg bid?
59 physicians have voted
Join Mednetto vote and see how they answered.
2 Answers
Mednet Member
Pulmonology · University of Kentucky Medical Center
Answered on
Several factors play into this decision for me.
- Is the patient obese? Obese patients tend to give me pause for dose-reduction of DOACs. As such, half-dose apixaban may have been relatively underdosed for an obese patient and I would not call it DOAC failure, rather I would increase the dose to usua...
Join for free or sign in to see the full answer
Mednet MemberInvited Expert
Pulmonology · Temple University Hospital
Answered on
Full dose for the rest of their life.
Join for free or sign in to see the full answer